SCHRODER INCOME GROWTH FUND PLC
Interim Management Statement for the Quarter ended 30 November 2009
The Board of Schroder Income Growth Fund Plc ("the Company") is pleased to announce its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules. This Statement is in respect of the period from 1 September 2009 to 30 November 2009.
Investment Objective
The Company's principal investment objectives are to provide real growth of income, being growth of income in excess of the rate of inflation, and capital growth as a consequence of the rising income.
First Interim Dividend for the year ended 31 August 2010
The Board has declared a first interim dividend of 1.60p net per share for the year ending 31 August 2010, payable on 29 January 2010 to shareholders on the register on 29 December 2009.
Annual General Meeting
The Annual General Meeting of the Company was held on 7 December 2009. All resolutions set out in the Notice of Meeting were duly passed.
Company Statistics as at 30 November 2009
Net Assets
|
£125.5 million
|
Net Asset Value per Ordinary Share (ex income)
|
181.04p
|
Share Price
|
170.75p
|
Discount
|
5.7%
|
Number of Portfolio Holdings
|
26
|
Source for all performance data: Fundamental Data.
Cumulative Performance* to 30 November 2009
Performance over |
3mnths |
6mnths |
1yr |
3yr |
5yr |
Share Price (Total Return) |
5.7% |
7.7% |
20.2% |
(7.7)% |
26.7% |
Net Asset Value (Total Return) |
5.2% |
15.4% |
17.4% |
(8.2)% |
27.0% |
FTSE All-Share Index (Total Return) |
5.9% |
19.7% |
29.3% |
(4.9)% |
34.9% |
Data Source: Fundamental Data.
Portfolio Information as at 30 November 2009
Ten Largest Holdings
Stock Name |
Sector Classification |
Market Value (£) |
% of Net Asset Value |
Royal Dutch Shell 'B' |
Oil & Gas |
11,670,866 |
9.30 |
BP |
Oil & Gas |
10,328,257 |
8.23 |
Vodafone Group |
Telecommunications |
9,348,089 |
7.45 |
GlaxoSmithKline |
Healthcare |
8,389,934 |
6.69 |
Unilever |
Consumer Goods |
7,440,386 |
5.93 |
British American Tobacco |
Consumer Goods |
6,739,851 |
5.37 |
AstraZeneca |
Healthcare |
6,232,227 |
4.97 |
HSBC Holdings |
Financials |
5,760,551 |
4.59 |
Imperial Tobacco Group |
Consumer Goods |
5,581,176 |
4.45 |
BAE Systems |
Industrials |
4,535,241 |
3.61 |
Sector Allocation
Sector |
% of Net Asset Value |
Consumer Goods |
18.44 |
Oil & Gas |
17.53 |
Financials |
16.29 |
Healthcare |
11.65 |
Consumer Services |
10.21 |
Utilities |
9.06 |
Telecommunications |
7.45 |
Industrials |
6.23 |
Net current assets |
3.14 |
Changes to Share Capital during the quarter ended 30 November 2009
None - there remain a total of 68,688,343 ordinary shares of 10p each in issue. Each share carries one voting right.
Material Events or Transactions
There have been no material events or transactions that have taken place in respect of the Company between 1 September 2009 and the date of publication of this Statement.
Company Information as at 30 November 2009
SEDOL Code |
0791586 |
AIC Sector |
Income and Growth |
Launch Date |
March 1995 |
Financial Year End |
31 August |
Next Dividend Payment Date |
29 January 2010 |
Enquiries:
Louise Richard
Schroder Investment Management Limited
Company Secretary
Tel: 0207 658 6501
11 December 2009